Philochem

Philochem is a wholly-owned subsidiary of Philogen. Philochem's mission is to innovate in ligand discovery and drug target identification.Philochem has discovered and developed innovative methods in the following areas: 1. Design, construction, and screening of DNA-encoded chemical libraries of unprecedented quality and scale; 2. Development of small molecule drug conjugates for cancer therapy; 3. Development of radiolabeled ligands for cancer imaging; 4. Development and application of chemoproteomic approaches for drug target discovery; 5. Mass spectrometric characterization of MHC peptidomes for the development of innovative immunomodulatory strategies. These technologies are integrated into drug discovery and product development programs.